Pretzel Therapeutics Revenue

Biotechnology Research • Boston, Massachusetts, United States • 21-50 Employees

Pretzel Therapeutics revenue & valuation

Annual revenue	$45,000,000
Revenue per employee	$1,000,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$144,000,000
Total funding	$72,500,000

Key Contacts at Pretzel Therapeutics

Peter Cicala

Co-Founder

Jordan Kerns

Director Of Biology

Andrew Mckenzie

Associate Director, Chemistry

Ying Carmona

Associate Director, Controller

Jonathan Novak

Senior Director Of Dmpk

Noa Rotem-Warner

Director Global Operations

Javier Miralles Fusté

Associate Director

Company overview

Headquarters	Boston, Massachusetts, United States
Website	pretzeltx.com
NAICS	541714
Employees	21-50
Socials

Pretzel Therapeutics Email Formats

Pretzel Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@pretzeltx.com), used 55.2% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@pretzeltx.com	55.2%
{first name}{last name}	johndoe@pretzeltx.com	24.1%
{last name}{last name}	doedoe@pretzeltx.com	13.8%
{first initial}	j@pretzeltx.com	6.9%

About Pretzel Therapeutics

Our mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology. Mitochondria are essential energy-converting cellular organelles found in nearly every cell type throughout the body. Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondrial dysfunction also plays an important role in more common diseases, including aging-related disorders. At Pretzel, we are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots. By taking aim at the genetic drivers of mitochondrial dysfunction, we believe our approach could be effective across a wide range of diseases which lack meaningful treatment options today.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Vice President

Entry

Director

Employees by Department

Pretzel Therapeutics has 11 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Pretzel Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-10-12	4	$72,500,000
2025-08-02	1	N/A

Funding Insights

$72,500,000

Total funding amount

Number of funding rounds

Pretzel Therapeutics Tech Stack

Discover the technologies and tools that power Pretzel Therapeutics's digital infrastructure, from frameworks to analytics platforms.

PWA

Miscellaneous

Perfmatters

Performance

MonsterInsights

Analytics

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Yoast SEO

SEO

Google Tag Manager

Tag managers

Nginx

Reverse proxies

Frequently asked questions

Pretzel Therapeutics is located in Boston, Massachusetts, US.

Pretzel Therapeutics generates an estimated annual revenue of $45,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Pretzel Therapeutics has an estimated valuation of $144,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Pretzel Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Pretzel Therapeutics has raised a total of $72,500,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.